OpenAlex
PricingAboutJobs
Log inGet started
Work

Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part I. Biotherapeutics

HTML

Year: 2015
Type: review
Source: Toxicologic Pathology
DOI: 10.1177/0192623315570340
Authors: Kendall S. Frazier, Jeffery A. Engelhardt, Pierluigi Fant, Silvia Guionaud, Scott P. Henry, Michael W. Leach, Calvert Louden, Marshall S. Scicchitano, James L. Weaver, Tanja S. Zabka
Institutions: GlaxoSmithKline (United States), Ionis Pharmaceuticals (United States), Pfizer (United States), United States Food and Drug Administration, Center for Drug Evaluation and Research, Genentech
Language: English

Topic: Immunotoxicology and immune responses
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: drug-induced vascular injury, biologic therapy, immunoglobulins, peptides, preclinical toxicology, regulatory toxicology, biomarkers, risk assessment, drug development, feedback regulation
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2097919342
FWCI: 0.309
Cites: 203
Cited by: 36
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security